Showing results (701-710 of 765) with videos related to
Sort By:
Pageof 77
Cell Metabolism|March 10, 2016
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic SubjectsSaswata Talukdar, Yingjiang Zhou, Dongmei Li, et al.Journal of Visualized Experiments : Jove|May 3, 2021
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace PigsGábor B Brenner, Zoltán Giricz, Rita Garamvölgyi, et al.Cardiovascular Research|June 12, 2021
AIM2-driven inflammasome activation in heart failureZsófia Onódi, Mihály Ruppert, Dániel Kucsera, et al.Cells|March 20, 2019
Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of Cyclooxygenase-2 by Rofecoxib in the RatBernadette Lázár, Gábor B Brenner, András Makkos, et al.Cardiovascular Research|January 31, 2023
Cardioprotective efficacy of limb remote ischaemic preconditioning in rats: discrepancy between a meta-analysis and a three-centre in vivo studyNabil V Sayour, Gábor B Brenner, András Makkos, et al.Nature Immunology|November 14, 2018
Metabolic reprogramming of natural killer cells in obesity limits antitumor responsesXavier Michelet, Lydia Dyck, Andrew Hogan, et al.Nature Genetics|February 19, 2020
Allele-specific expression changes dynamically during T cell activation in HLA and other autoimmune lociMaria Gutierrez-Arcelus, Yuriy Baglaenko, Jatin Arora, et al.Lupus|February 17, 2018
Combined detection of uMCP-1 and uTWEAK for rapid discrimination of severe lupus nephritisX W Dong, Z H Zheng, J Ding, et al.Cells|March 1, 2020
Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/ReperfusionGábor B Brenner, András Makkos, Csilla Terézia Nagy, et al.Proceedings of the National Academy of Sciences of the United States of America|December 2, 2015
Human autoreactive T cells recognize CD1b and phospholipidsIldiko Van Rhijn, Twan van Berlo, Tamara Hilmenyuk, et al.Pageof 77